⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9368619 | 1.00 | — | — | |
| SCHEMBL277789 | 0.92 | — | — | |
| SCHEMBL7259802 | 0.90 | FDPS (0.46) | — | |
| SCHEMBL276282 | 0.90 | FDPS (0.46) | — | |
| SCHEMBL4699570 | 0.90 | FDPS (0.46) | — | |
| SCHEMBL7263751 | 0.90 | FDPS (0.46) | — | |
| SCHEMBL1831666 | 0.90 | FDPS (0.46) | — | |
| SCHEMBL2670965 | 0.90 | FDPS (0.46) | — | |
| SCHEMBL14732171 | 0.90 | FDPS (0.46) | — | |
| SCHEMBL276114 | 0.90 | FDPS (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024149215-A1 | DESIGNED PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-07-18 | — | — | WO | claimed |
| US-20240238390-A1 | PEPTIDES FOR THE TREATMENT OF CANCER AND/OR METASTASIS | BCN PEPTIDES, S.A. (ES) | 2024-07-18 | — | — | US | claimed |
| EP-4385516-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Shenzhen Winkey Technology Co., Ltd. (CN) | 2024-06-19 | — | — | EP | claimed |
| WO-2024109878-A1 | PEPTIDE HAVING ANTI-AGING EFFECT, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-05-30 | — | — | WO | claimed |
| CN-113490680-B | Peptides and compositions for cosmetic use | 利波特鲁有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2024078588-A1 | NEW USE OF PEPTIDE COMPOUND IN PREPARATION OF COMPOSITION FOR SKIN AGING REPAIR | 深圳市维琪科技股份有限公司 | 2024-04-18 | — | — | WO | claimed |
| CN-117203217-A | Polypeptide and cosmetic composition or medicinal composition and application thereof | 深圳市维琪科技股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-117088944-A | Pentapeptide, composition and application thereof | 深圳市维琪科技股份有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-116964071-A | Hexapeptide and cosmetic composition or medicinal composition and application thereof | 深圳市维琪科技股份有限公司 | 2023-10-27 | — | — | CN | claimed |
| WO-2023184114-A1 | POLYPEPTIDE AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2023-10-05 | — | — | WO | claimed |
| EP-1664093-A1 | NEW ANTITUMORAL COMPOUNDS | Pharma Mar, S.A.U. (ES) | 2006-06-07 | — | — | EP | claimed |
| WO-2005023846-A1 | NEW ANTITUMORAL COMPOUNDS | PHARMA MAR, S.A.U. (ES) | 2005-03-17 | — | — | WO | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-0559625-B1 | Esters of L-carnitine and acyl L-carnitine endowed with muscle relaxant activityselective on gastrointestinal tract and pharmaceutical compositions containing same | SIGMA TAU IND FARMACEUTI (IT) | 1997-08-27 | — | — | EP | claimed |
| EP-0634392-B1 | Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock | SIGMA TAU IND FARMACEUTI (IT) | 1997-02-05 | — | — | EP | claimed |
| EP-0634392-A2 | Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1995-01-18 | — | — | EP | claimed |
| US-5352689-A | Rhizoxin derivatives and their use as anti-tumor agents | SANKYO COMPANY, LIMITED (JP) | 1994-10-04 | — | — | US | claimed |
| EP-0559625-A2 | Esters of L-carnitine and acyl L-carnitine endowed with muscle relaxant activityselective on gastrointestinal tract and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1993-09-08 | — | — | EP | claimed |